PARP1 and colitis: These results were concordant with the anti‐inflammatory effect of PARP inhibitors in mouse models of colitis, suggesting that PARP inhibitors might be used in the treatment of inflammatory diseases.[26, 27] Therefore, we anticipate the application of PARP inhibitors being applied in other non‐oncological diseases, particularly CD.